Incheon Free Economic Zone (IFEZ), GE Healthcare and Bio Research Complex (BRC) announced the signing of a five year plan to invest in the establishment of the “GE Global Ubiquitous Health Research and Development Center” (GE Global u-Health R&D Center).

Under the agreement with IFEZ, GE Healthcare, a global leader in transformational medical technologies and services, and BRC, a respected provider of gene analysis technology, will use the facility for research and development activities related to healthcare IT solutions.

Sang-soo Ahn, the mayor of the Incheon Metropolitan City in which IFEZ is located said, The agreement is a perfect example of a collaboration between the Korean government, a local company like BRC and a global company like GE. The establishment of the GE Global u-Health R&D Center will be a triggering event in the expansion of IFEZ’s IT and healthcare infrastructure and the buildup of a research network. We’re hoping IFEZ can position itself as the world’s premier project site that best realizes ubiquitous-Health programs, going forward.

Healthymagination is GE’s $6 billion commitment to improve health care access, affordability and quality through advanced technologies, research and development.

Dilon Diagnostics announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its lesion-localization system for molecular imaging biopsy guidance.

GammaLoc® is a complementary technology to Dilon’s cornerstone product, the Dilon 6800® Gamma Camera. The GammaLoc® (GL) system will help doctors accurately locate breast lesions and enable gamma-guided biopsies, particularly useful for patients that have findings on the Dilon system that are not revealed with other imaging modalities.

The GammaLoc® system utilizes a CorreLocator™ paddle and a StereoView™ imaging collimator system - a technique similar to that used in stereotactic X-ray localization, and the GammaLoc® software calculates the specific location of the suspect lesion. The compact design allows for breast biopsies with optimal patient comfort; and the entire system is small and portable, allowing physicians to perform molecular imaging guided biopsy procedures anywhere on site.